Consumer Defensive
Cupid Limited (cupid) Q1 FY27: Revenue Exceeding ₹150 Cr
Cupid Limited (CUPID) set to deliver revenue exceeding ₹150 Cr in Q1 FY27, management revises medium-term growth outlook upwards.
Cupid Limited (Cupid, The Company), Bharat’s rapidly growing consumer wellness and personal care company, is on track to deliver revenue exceeding ₹150 Cr in the first quarter of FY27, marking one of the strongest quarterly performances in the Company’s history. This exceptional start to the financial year and improved visibility across international & domestic markets have led the management to revise its FY27 revenue outlook upwards by a minimum of 10%.
Key Growth Drivers
The revised FY27 revenue outlook is supported by multiple long-term growth drivers:
Expanding opportunities across international B2B healthcare markets, driven by rising demand from institutional buyers, private sector customers, and government procurement programmes.
Successful commencement of the Company’s long-term supply agreement with Partnership for Supply Chain Management (PFSCM), Netherlands, strengthening its position in global healthcare procurement.
Strong order visibility across private markets, institutional business, and international tenders spanning multiple geographies.
Continued growth in the Male Condom (MC) and Female Condom (FC) businesses, supported by enhanced manufacturing capabilities, customer acquisition, and wider market reach over the past twelve months.
Growing opportunities in the lubricant portfolio, backed by increasing acceptance across both institutional and consumer channels.
Significant long-term potential in the consumer business as the Company continues to build a mainstream personal care and wellness brand with an expanding presence across modern trade, organised retail, and pharmacy networks across Bharat.
Ongoing capacity expansion, operational efficiencies, and backward integration initiatives expected to support sustained growth while improving profitability.
Active participation in IVD kits and menstrual cup tenders across multiple states. The Company also continues to make steady progress in its In Vitro Diagnostics (IVD) business.
Commenting on the Company’s performance, Mr. Aditya Kumar Halwasiya, Chairman & Managing Director, Cupid Limited, said, ‘Our strong start to FY27 reflects the transformation Cupid has undergone over the past few years. We have built a diversified business with multiple growth engines that are now beginning to scale together. We are seeing strong momentum across our international B2B business, supported by expanding opportunities in private markets, institutional procurement, and government tenders across the world. Our strategic relationship with PFSCM has commenced on a very encouraging note and further strengthens our long-term position in global healthcare procurement. Over the past twelve months, we have significantly strengthened our Male Condom and Female Condom businesses through enhanced manufacturing capabilities, customer acquisition, and wider market reach. At the same time, our lubricants portfolio continues to gain traction across both institutional and consumer segments. On the consumer side, we remain focused on building Cupid into a trusted mainstream personal care and wellness brand. We see significant long-term opportunities across modern trade, organised retail, and pharmacy channels as we continue to expand our presence across Bharat. Our IVD business remains an exciting growth opportunity. While our current internal projections for this vertical remain deliberately conservative, we believe it has the potential to become a meaningful contributor to Cupid’s growth over the coming years as our product portfolio expands and commercialisation progresses. Given the strength of our current order book, improving visibility across international markets, and the wide range of opportunities ahead, we have revised our medium-term revenue outlook upward. At the same time, we believe our projections remain conservative, leaving room for additional upside as execution continues and new opportunities materialise. We also expect our profit margins to remain strong, supported by favourable USD-INR realisations and an overall upward trend in pricing. On net profit margins, we are confident of delivering performance ahead of our current guidance. In addition, we plan to operationalise our new Palava manufacturing facility in the coming quarter, further strengthening our production capabilities and supporting future growth. As always, we remain committed to disciplined execution, prudent capital allocation, and creating sustainable long-term value for all our stakeholders.’
Cupid Limited enters the remainder of FY27 with one of the strongest order books and opportunity pipelines in its history. Backed by expanding global demand, a diversified business portfolio, growing manufacturing capabilities, and continued investments across healthcare, personal care, and wellness, the Company is well positioned to deliver sustainable long-term growth. Management believes the Company is entering a new phase of growth, with multiple business verticals expected to contribute meaningfully to revenue and profitability in the years ahead.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Cupid Limited
Cupid Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Cupid gains 118.7% over three months and trades near its 52-week highs. The PEG stands at 4.73 — severely stretched. Any earnings miss could trigger a sharp de-rating. Industry-leading margins of 28.9% reflect exceptional pricing power and operational efficiency. RSI hits 89, a level that signals the stock runs hot. Notably, buyers drove volume on 26 recent sessions — though at these levels, some profit-taking is normal. The stock rises 118.7% in three months on 32.0% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cupid Limited.
Consumer Defensive
Piccadily Agro Industries Limited (piccadil) Q2 FY27: Distillery Revenue Grows 30.5% YOY
Piccadily Agro Industries Ltd. reports a 30.5% YOY growth in distillery revenue for Q2 FY27, driven by premium spirits.
Piccadily Agro Industries Limited (PAIL), one of India’s leading producers of premium alcoholic beverages, announced its financial results for the quarter ended September 30, 2026. The Company reported a revenue from operations of INR 277.9 crore in Q2 FY27, up 19.4% YoY from INR 232.7 crore in the corresponding quarter last year, driven by continued momentum in its Distillery business. Distillery revenue increased 30.5% YoY to INR 271.3 crore and accounted for 97.6% of the Company’s quarterly revenue, compared with 89.3% in Q2 FY26.
Distillery Performance
The Distillery business remains the principal growth engine, with its increasing contribution reflecting the progress made in strengthening Piccadily’s spirits-led business. The scaling up of the Chhattisgarh Distillery, together with enhanced manufacturing capabilities, positions the company well to support long-term growth ambitions.
Product Innovation and Expansion
The Company continues to advance its strategic focus on strengthening its premium, super-premium, and luxury spirits portfolio, expanding market presence and distribution, enhancing brand equity, and leveraging its expanded manufacturing capabilities to drive sustainable long-term growth. Recent product introductions, including Indri Ilika, Indri Agneya, and the Diwali Collector’s Edition 2026, further reinforce the depth and premium positioning of its portfolio.
Future Outlook
Commenting on the results, Mr. Natwar Agarwal, Chief Financial Officer, Piccadily Agro Industries Limited, said, “Q2 FY27 saw continued momentum in our core Distillery business, which grew over 30% YoY, while overall Company revenue increased by 19.4%. Our H1 FY27 PAT is higher than the corresponding period last year, reflecting the underlying strength of our business and continued progress towards our financial objectives. The Company remains firmly on track to achieve its business objectives, with a continued focus on building differentiated brands, expanding its distribution footprint, strengthening manufacturing capabilities, and deepening its presence across domestic and international markets.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Piccadily Agro Industries Limited
Piccadily Agro Industries Limited belongs to the Consumer Defensive › Beverages – Wineries & Distilleries sector. Here’s a quick read on where the business and the stock stand today.
Piccadily moves sideways over three months, with neither buyers nor sellers taking control. The PEG of 0.49 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. The business compounds revenue at 19.5% and profits at 83.3% CAGR. That is strong double-digit growth on both counts. The stock gains 3.6% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 19.5% and profits at 83.3% CAGR, with D/E of 0.00. Meanwhile, the stock dips 7.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Piccadily Agro Industries Limited.
Consumer Defensive
Procter & Gamble Hygiene and Health Care Ltd. Q2 FY27: Sales Flat, PAT Down 7%
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) reports flat sales and a 7% drop in PAT for Q2 FY27, driven by cost fluctuations.
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) today announced its financial results for the second quarter ended September 30, 2026. The company reported sales of ₹ 1145 crores, flat versus the same quarter last year. Profit After Tax (PAT) was reported at ₹196 crores, down 7% versus the same period last year.
Impact of Cost Fluctuations
In the quarter, the company experienced a double-digit impact on profitability driven by commodity cost fluctuations and headwinds like raw material and energy costs, as well as unfavorable foreign exchange rates. However, a significant portion of this was offset by the robust productivity program.
Strategic Investments
In the quarter, the company also continued to significantly invest back in innovation and advertising & promotion (versus past quarter) – in an endeavor to position the company for long-term competitiveness and value creation.
Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “We continue to invest strategically in our brands, innovation and market capabilities, even as the macro-economic landscape remains challenging. We continue to believe that our strategic priorities, combined with the strength of our brands and organizational capabilities, position us well to leverage future growth opportunities and create sustainable long-term value for all our stakeholders. We are excited about the future.”
The first half of FY 2026–27 was marked by sustained innovation across our vectors of superiority. Key milestones include the launches of the upgraded Vicks ZzzQuil with Ashwagandha and Vicks medicated lozenges, alongside the ongoing evolution of our media model to better engage consumers where they are. The Company continues to focus on, and drive, Whisper Period Pants to delight consumers with 360-degree leakage protection.
As we look ahead, we remain committed to our Integrated Growth Strategy, focusing on a focused product portfolio of daily use categories where performance drives brand choice, superiority, productivity, constructive disruption, and an agile and accountable organization to deliver balanced growth and value creation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Procter drops 15.1% over three months and trades near its 52-week lows. D/E sits at 0.00 with a 3.22% dividend and unbroken revenue growth. Financial stability is a genuine strength. The PEG of 2.08 is on the high side. However, it is acceptable for a quality compounder with a strong moat. Sellers drive 2.6x the volume of buyers. Furthermore, they controlled 18 of recent sessions versus 12 for buyers — a clear distribution signal. The business compounds at 4.1% revenue and 14.2% profit CAGR, with D/E of 0.00. Yet the stock drops 15.1% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Procter & Gamble Hygiene and Health Care Limited.
Consumer Defensive
Cupid Limited (NSE: Cupid) Q2 FY27: Net Profit Growth of 133% Yoy; H1 FY27 Net Profit Rises 156% Yoy to ₹100.37 Crore
Cupid Limited (NSE: CUPID) reports Q2 FY27 net profit growth of 133% YoY and H1 FY27 net profit rises 156% to ₹100.37 crore.
Cupid Limited (NSE: CUPID), a leading consumer wellness and personal care company, announced its unaudited financial results for the quarter and half year ended 30th September, 2026. The company reported a net profit growth of 133% YoY for Q2 FY27 and a net profit rise of 156% YoY to ₹100.37 crore for H1 FY27. The total income for Q2 FY27 stood at ₹208.97 crore, marking a 132% YoY increase. Moreover, H1 FY27 total income grew 136% to ₹365.95 crore. Cupid Limited has raised its FY27 guidance to ₹880+ crore revenue and ₹275+ crore net profit.
Q2 FY27 Financial Highlights
Cupid Limited’s Q2 FY27 total income was ₹208.97 crore, up 132% YoY. The operating income was ₹187.86 crore, showing a 122% YoY increase. The net profit for the quarter was ₹56.22 crore, reflecting a 133% YoY growth. The EBITDA margin was 29%.
H1 FY27 Financial Highlights
For H1 FY27, the total income increased to ₹365.95 crore, growing 136% YoY. The net profit for the half year was ₹100.37 crore, up 156% YoY. The EBITDA stood at ₹114.83 crore, marking a 156% YoY increase. The company continues to focus on strengthening its product mix, sourcing efficiencies, and scale benefits as its Consumer Healthcare & FMCG business expands across organized retail channels.
Future Outlook
Cupid Limited anticipates H2 FY27 to be significantly stronger due to the commissioning of the Palava facility in Q3 FY27 and the expansion of its retail partnerships. The company expects to add manufacturing capacity and enhance its presence in organized retail, which will likely drive higher volumes in the second half of the fiscal year. Cupid Limited has also raised its guidance for FY28 and FY29, projecting revenues of ₹1,305+ crore and ₹1,950+ crore, respectively, with corresponding net profits of ₹390 crore and ₹605 crore.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Cupid Limited
Cupid Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Cupid gains 20.1% over three months and trades near its 52-week highs. The PEG stands at 6.97 — severely stretched. Any earnings miss could trigger a sharp de-rating. Industry-leading margins of 30.4% reflect exceptional pricing power and operational efficiency. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock rises 20.1% in three months on 31.2% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cupid Limited.
-
HIRECT3 days agoHirect Limited Q2 & H1 FY27: Highest-ever Revenue, Strong Business Momentum
-
Consumer Cyclical3 days agoKalyan Jewellers India Limited (kalyankjil) Q2 FY27: Revenue Surpasses Rs 10,300 Crore, PAT Rises 64%
-
Basic Materials3 days agoVishnu Chemicals Limited Q2fy27: Strategic JV with DCX Chrome SAS, Ebitda Grows 10% Yoy
-
Credit Services3 days agoIifl Finance Limited to Raise ₹6,414 Crores ($686 Million) in Major Private Equity Infusion
-
Basic Materials3 days agoJindal Stainless Limited (JSL) Wins 95 Gold and 6 Silver Awards at QCFI Conventions 2026
-
Communication Services3 days agoMatrimony.com Limited Q2 FY26: PAT Growth of 167% Y/y
-
ADANIENT2 days agoAdani Enterprises Limited (adanient) Kutch Copper First Indian Producer to Receive Veramark Assurance Certification
-
Consumer Defensive2 days agoCupid Limited (NSE: Cupid) Q2 FY27: Net Profit Growth of 133% Yoy; H1 FY27 Net Profit Rises 156% Yoy to ₹100.37 Crore